2,930 Shares in HCA Healthcare, Inc. (NYSE:HCA) Purchased by Oxford Asset Management LLP

Oxford Asset Management LLP bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 2,930 shares of the company's stock, valued at approximately $879,000.

A number of other large investors also recently bought and sold shares of the business. Congress Wealth Management LLC DE increased its holdings in HCA Healthcare by 3.4% during the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock worth $312,000 after purchasing an additional 34 shares during the period. Evergreen Private Wealth LLC grew its position in shares of HCA Healthcare by 0.3% in the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock worth $3,838,000 after buying an additional 35 shares during the last quarter. Mediolanum International Funds Ltd increased its holdings in shares of HCA Healthcare by 0.3% during the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock valued at $3,153,000 after acquiring an additional 36 shares in the last quarter. Prairie Wealth Advisors Inc. increased its holdings in shares of HCA Healthcare by 6.1% in the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock valued at $210,000 after purchasing an additional 40 shares during the period. Finally, Whittier Trust Co. lifted its holdings in shares of HCA Healthcare by 3.6% during the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock worth $359,000 after purchasing an additional 41 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm's stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company's stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have commented on HCA shares. Baird R W cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. StockNews.com raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday. Cantor Fitzgerald reissued an "overweight" rating and issued a $405.00 price objective on shares of HCA Healthcare in a report on Monday, January 27th. Robert W. Baird reissued a "neutral" rating and issued a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Finally, Royal Bank of Canada cut their target price on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a report on Monday. One analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of "Moderate Buy" and a consensus target price of $381.13.

HCA Healthcare Price Performance

NYSE HCA traded up $8.74 during mid-day trading on Tuesday, hitting $340.76. The stock had a trading volume of 1,416,571 shares, compared to its average volume of 1,396,128. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The firm's 50 day moving average is $330.05 and its 200 day moving average is $331.32. The stock has a market capitalization of $83.90 billion, a price-to-earnings ratio of 15.51, a PEG ratio of 1.10 and a beta of 1.48.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The firm had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. During the same period in the previous year, the business posted $5.36 earnings per share. HCA Healthcare's quarterly revenue was up 5.7% on a year-over-year basis. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.85%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.